Fogarty International Center

Fogarty International Center

On behalf of the Fogarty International Center at the U.S. National Institutes of Health (NIH), the following funding opportunities, notices and announcements may be of interest to those working in the field of global health research. Updates are typically distributed once a week.

Funding Opportunities NIH funding opportunities for which foreign organizations, foreign components of U.S. organizations and/or other foreign components may apply. HIV Drug Resistance: Genotype-Phenotype-Outcome Correlations (R01 Clinical Trial Not Allowed) (RFA-AI-18-029) Application Receipt Date(s): December 5, 2018 Funding supported through the NIH Common Fund’s Somatic Cell Genome Editing program Application Receipt Date(s): October 18, 2018 Development of Cell and Tissue Platforms to Detect Adverse Biological Consequences of Somatic Cell Genome Editing (U01 Clinical Trial Not Allowed) (RFA-RM-18-022) Innovative Technologies to Deliver Genome Editing Machinery to Disease-relevant Cells and Tissues (UG3/UH3 Clinical Trial Not Allowed) (RFA-RM-18-023) Expanding the Human Genome Engineering Repertoire (U01 Clinical Trial Not Allowed) (RFA-RM-18-024) Innovative Technologies to Non-Invasively Monitor Genome Edited Cells In Vivo (UH2/UH3 Clinical Trial Not Allowed) (RFA-RM-18-025) Notice of Pre-Application Webinar for the NIH Common Fund Somatic Cell Genome Editing program (NOT-RM-18-020) Novel Approaches for Relating Genetic Variation to Function and Disease (R21 Clinical Trial Not Allowed) (PA-18-867) and (R01 Clinical Trial Not Allowed) (PA-18-868) Application Receipt/Submission Date(s): Standard dates apply Research to Advance Vaccine Safety (R21 Clinical Trial Not Allowed) (PA-18-872) and (R01 Clinical Trial Not Allowed) (PA-18-873) Application Receipt/Submission Date(s): Standard dates apply Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) (PAR-18-869) Application Receipt/Submission Date(s): November 7, 2018; and more Spectrum of Alzheimers Disease and Age-related Cognitive Decline Early Stage Clinical Trials (R01 Clinical Trial Optional) (PAR-18-877) Late Stage Clinical Trials (R01 Clinical Trial Required) (PAR-18-878) Application Receipt/Submission Date(s): Standard dates apply BRAIN Initiative: Development of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in Human and Non-Human Primate Brain (UG3/UH3 Clinical Trial Optional) (RFA-MH-19-135) Application Receipt Date(s): October 9, 2018; and more Expanding Extramural Research Opportunities at the NIH Clinical Center (U01 Clinical Trial Optional) (PAR-18-879) Application Receipt/Submission Date(s): December 3, 2018; and more Discovery of Biomarkers, Biomarker Signatures, and Endpoints for Pain (R61/R33 Clinical Trial Optional) (RFA-NS-18-041) Application Receipt Date(s): November 27, 2018; and more Novel Approaches to Safe, Non-Invasive, Real Time Assessment of Human Placenta Development and Function Across Pregnancy (R01 - Clinical Trial Not Allowed) (PAR-18-884) and (R21 - Clinical Trial Not Allowed) (PAR-18-885) Application Receipt/Submission Date(s): December 4, 2018; and more Notice of Joint DMS/NIGMS Initiative to Support Research at the Interface of the Biological and Mathematical Sciences (NOT-GM-18-041) Note: The project description should document the need for and nature of collaborations, including possible mentoring of U.S. students at a foreign site. NIH funding opportunities for which United States small business concerns (SBCs) may collaborate with a foreign business entity. BRAIN Initiative: Development Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (STTR) (R41/R42 - Clinical Trials Not Allowed) (PA-18-870) and (SBIR) (R43/R44 - Clinical Trial Not Allowed) (PA-18-871) Application Receipt/Submission Date(s): Standard dates apply Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional) (RFA-MD-18-009) and (R41/R42- Clinical Trial Optional) (RFA-MD-18-010) Application Receipt Date(s): October 1, 2018 Information related to opportunities from other organizations focusing on global health and foreign collaboration. Call for evidence on conducting ethical research in global health emergenciesfrom the Nuffield Council on Bioethics Reply by Aug 17, 2018

Funding News

NIH funding news that may be relevant to global health researchers.

• NIH/AHRQ Application Submission/Resubmission Policy (NOT-OD-18-197)
• NIH Offers Assistance to Phase II HHS SBIR and STTR Awardees through the NIH Commercialization Accelerator Program (CAP) 2018-2019 (NOT-OD-18-213)
• Update on NIHs Next Generation Researchers Initiative (NGRI) Policy on Early Established Investigators (EEIs) (NOT-OD-18-214)
• Update - NIH Response to Registration Issues in Sam.gov (NOT-OD-18-215)
• Soliciting Feedback on the BRAIN Initiative (NOT-NS-18-075)
• NCI Request for Information (RFI): Input on Development of an NCI Cancer Biomarker Data Aggregator (NOT-CA-18-095)
• Request for Information (RFI): Strategies for Advancing Sepsis Research Supported by NIGMS (NOT-GM-18-039)
• FDA Standard Core Clinical Outcome Assessments and Endpoints (NOT-FD-18-014)
• Notice of Intent to Publish a Funding Opportunity Announcement for Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Optional) (NOT-MH-18-037) and (R21 Clinical Trial Optional) (NOT-MH-18-038)
• Notice of Intent to Publish a Funding Opportunity Announcement for End-of-Life and Palliative Care Approaches to Advanced Signs and Symptoms (R01- Clinical Trial Optional) (NOT-NR-18-013) and (R21- Clinical Trial Optional) (NOT-NR-18-014)
• Notice of Intent to Publish a Funding Opportunity Announcement for NINR Clinical Trial Planning Grant (R34- Clinical Trial Optional) (NOT-NR-18-015)
• Notice of Additional Guidance for Alzheimer's Clinical Trials Consortium (ACTC) Applicants (NOT-AG-18-023)

Upcoming Deadlines

• Fogarty HIV Research Training
  Application deadline: August 23, 2018
• Mobile Health: Technology and Outcomes in LMICsApplication deadline: August 31, 2018
• Emerging Global Leader Award
  November 7, 2018
• Global Brain and Nervous System Disorders Research Across the Lifespan
  November 7, 2018